Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: An association of CD9 with α3β1 integrin

British Journal of Dermatology

Volumn 137, Issue 6, 1997, Pages 856-863

  Okochi, H ^a   Kato, M ^b   Nashiro, K ^a   Yoshie, O ^c   Miyazono, K ^b   Furue, M ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER INSTITUTE   (Japan)

^c SHIONOGI AND CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD63 ANTIGEN; CD81 ANTIGEN; CD9 ANTIGEN; INTEGRIN; MEMBRANE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; IMMUNOPRECIPITATION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKIN CANCER; TISSUE DISTRIBUTION;

EID: 0031448867     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb01544.x     Document Type: Article

References (29)

1. Sonnenberg A. Integrins and their ligands. Curr Top Microbiol Immunol 1993; 184: 7-35.
2. Miyamoto S, Akiyama SK, Yamada KM. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 1995; 267: 883-5.
3. Carter WG, Wayner EA, Bouchard TS, Kaur P. The role of integrins α2β1 and α3β1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol 1990; 110: 1387-404.
4. Cavani A, Zambruno G, Marconi A et al. Distinctive integrin expression in the newly forming epidermis during wound healing in humans. J Invest Dermatol 1993; 101: 600-4.
5. Stamp GWH, Pignatelli M. Distribution of β1, α1, α2 and α3 integrin chains in basal cell carcinoma. J Pathol 1991; 163: 307-13.
6. Rubinstein E, Le Naour F, Billard M et al. CD9 antigen is an accessory subunit of the VLA integrin complexes. Eur J Immunol 1994; 24: 3005-13.
7. Kersey JH, LeBien TW, Abramson CS et al. p24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody. J Exp Med 1981; 153: 726-31.
8. Horejsi V, Vlcek C. Novel structurally distinct family of leukocyte surface glycoproteins including CD9, CD37, CD53 and CD63. FEBS Lett 1991; 288: 1-4.
9. Imai T, Kakizaki M, Nishimura M, Yoshie O. Molecular analyses of the association of CD4 with two members of the transmembrane 4 superfamily. CD81 and CD82. J Immunol 1995; 155: 1229-39.
10. Jennings LK, Crossno JT, White MM. CD9 cluster workshop report: cell surface binding and functional analysis. In: Leucocyte Typing V (Schlossman SF et al., eds), Vol. 2. Oxford: Oxford University Press, 1995: 1249-51.
11. Moldenhauer G, Moller P, Schwartz-Albiez, R. CD37 workshop panel report. In: Leukocyte Typing V (Schlossman SF et al., eds). Vol. 1. Oxford: Oxford University Press, 1995: 544-6.
12. Amiot M. CD53 workshop panel report. In: Leukocyte Typing V (Schlossman SF et al., eds). Vol. 1. Oxford: Oxford University Press, 1995: 556-8.
13. Azorsa DO, Hildreth JEK. CD63 cluster workshop report. In: Leukocyte Typing V (Schlossman SF et al., eds). Vol. 2. Oxford: Oxford University Press, 1995: 1352-3.
14. Tedder TF, Wagner N, Engel P. CD81 workshop report. In: Leucocyte Typing V (Schlossman SF et al., eds). Vol. 1. Oxford: Oxford University Press, 1995: 684-8.
15. Engel P, Wagner N, Tedder TF. CD82 workshop report. In: Leucocyte Typing V (Schlossman SF et al., eds). Vol. 1. Oxford: Oxford University Press, 1995: 691-5.
16. Imai T, Fukudome K, Takagi S et al. C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. J Immunol 1992; 149: 2879-86.
17. Kitajima Y, Inoue S, Nagao S et al. Biphasic effects of 12-O-tetradecanoylphorbol-13-acetate on the cell morphology of low calcium-grown human epidermal carcinoma cells: involvement of translocation and down regulation of protein kinase C. Cancer Res 1988; 48: 964-70.
18. Tigalonowa M, Bjerke JR, Matre R. Fc gamma-receptors on Langerhans' cells and keratinocytes in suspension from normal skin characterized using soluble immune complexes and monoclonal antibodies. Acta Derm Venereol (Stockh) 1991; 71: 99-105.
19. Nunes IP, Johannessen AC, Matre R, Kristoffersen T. Epithelial expression of HLA class II antigens and Fc gamma receptors in patients with adult periodontitis. J Clin Periodontol 1994; 21: 526-52.
20. Bradbury LE, Kansas GS, Levy S et al. The CD19/CD21 signal transducing complex of human B lymphocytes include the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 1992; 149: 2841-50.
21. Angelisova P, Hilgert I, Horejsi V. Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class glycoproteins. Immunogenesis 1994; 39: 249-56.
22. Berditchevski F, Bazzoni G, Hemler ME. Specific association of CD63 with the VLA-3 and VLA-6 integrins. J Biol Chem 1995; 270: 17784-90.
23. Slupsky JR, Seehafer JG, Tang SC et al. Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex. J Biol Chem 1989; 264: 12289-93.
24. Metzelaar MJ, Wijngaard PLJ, Peters PJ et al. CD 63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 1991; 266: 5239-45.
25. Schwartz-Albiez R, Dorken B, Hofmann W, Moldenhauer G. The B cell-associated CD37 antigen (gp40-52) structure and subcellular expression of an extensively glycosylated glycoprotein. J Immunol 1988; 140: 905-14.
26. Si Z, Hersey P. Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma. Int J Cancer 1993; 54: 37-43.
27. Ikeyama S, Koyama M, Yamaoka M et al. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 1993; 177: 1231-7.
28. Nakamura K, Iwamoto R, Mekada E. Membrane-anchored heparin binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin α3β1 at cell-cell contact sites. J Cell Biol 1995; 129: 1691-705.
29. Higashiyama S, Iwamoto R, Goishi K et al. The membrane protein CD9/DRAP27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol 1995; 128: 929-38.